Speaking Engagements
On April 19-22, 2009, the National Business Incubation Association will be hosting its 23rd International Conference on Business Incubation in Kansas City, Missouri. Jeremy Lowe, representing Axinn, Veltrop & Harkrider, will be a featured lecturer at this year's conference, which is the premier training event for incubation professionals worldwide. Jeremy's lecture is entitled "An Entrepreneurial Company's Guide to Developing Profits from Patent Assets," and he will teach companies how to use patents as business tools having functions strategically aligned with their business goals and objectives. For more information, go to www.nbia.org.
On March 30 and 31, 2009, the American Conference Institute will be hosting its annual FDA Boot Camp - Basic Training for Products Liability and Patent Lawyers at the Millenium Broadway Hotel in New York. Chad Landmon from Axinn, Veltrop & Harkrider LLP will be one of premier speakers at the conference, which includes a "Who's Who of the nation's Food and Drug bar" who will discuss critical FDA issues for patent and product liability lawyers, including the recent changes enacted in the FDA Amendments Act of 2007. Chad's presentation will discuss bioequivalence and how it impacts patent issues. To register, call (888)224-2480 or go to americanconference.com/FDAbootcampNYC.
On February 25-27, 2009, the Licensing Executives Society will be hosting the Winter Meeting in San Antonio, Texas, centered on the theme "Licensing: A Global Culture - Embrace the Professionalism." Jeremy Lowe, representing Axinn, Veltrop & Harkrider, will be one of several experts speaking at the conference, which targets the high technology, chemicals, energy, environment and materials sectors, all in the context of professionalism on the global stage as it relates to licensing and technology transfer. Jeremy's presentation is entitled "Due Diligence in the Patent Evolution Era," and he will discuss patent valuation and due diligence strategies in the context of mergers and acquisitions, and how recent changes in the law can impact such strategies. For more information, go to www.lesusacanada.org
The American Conference Institute will be holding its Paragraph IV on Trial Conference in New York on November 19-20, 2008. Chad Landmon, a partner at Axinn, Veltrop & Harkrider LLP will be one of several experts speaking at the conference, at which patent litigators experienced in representing both generic and brand name drug manufacturers will work through a mock trial based on a real world ANDA filing. Chad will discuss proven, pre-litigation strategies for successfully preparing for Paragraph IV cases. To register, call 1-888-224-2480, or visit http://www.patentdocs.net/patent_docs/2008/07/aci-paragraph-i.html.
On October 15th and 16th, the Center for Business Intelligence will host the CBI’s Pharmaceutical Congress on Paragraph IV Disputes at the Marriot Philadelphia Downtown. Chad Landmon and Michael Davitz, representing Axinn, Veltrop, & Harkrider LLP, will be two of 21 featured speakers at the conference, which focuses on Paragraph IV litigation. The event will feature a mock paragraph IV dispute with a hypothetical patent, with attendees assuming their roles and developing litigation strategies. Chad and Michael will provide expertise on counseling and litigation services relating to patent, FDA and antitrust issues involving the development and marketing of new and generic drugs products. To register, call 800-817-8601 or go to www.cbinet.com.
On September 22nd and 23rd, the American Conference Institute will be hosting the Boston edition of the FDA Boot Camp - Basic Training for Products Liability and Patent Lawyers at the Sheraton Boston Hotel. Chad Landmon, representing Axinn, Veltrop & Harkrider, will be one of 17 featured speakers at the conference, which focuses on the critical FDA issues for patent and product liability lawyers, including the recent changes enacted in the FDA Amendments Act of 2007 (FDAAA). Chad's presentation will discuss bioequivalence and detail how it impacts patent issues. To register, call 888-224-2480 or go to americanconference.com/FDAbootcampbos.